Effect of Bezafibrate on Very Long Chain Fatty Acid Metabolism in Men With X-linked Adrenoleukodystrophy (X-ALD).

Trial Profile

Effect of Bezafibrate on Very Long Chain Fatty Acid Metabolism in Men With X-linked Adrenoleukodystrophy (X-ALD).

Completed
Phase of Trial: Phase II

Latest Information Update: 09 Aug 2011

At a glance

  • Drugs Bezafibrate (Primary)
  • Indications Adrenoleucodystrophy
  • Focus Pharmacodynamics
  • Acronyms BEZA
  • Most Recent Events

    • 09 Aug 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 09 Aug 2011 Actual end date (Aug 2011) added as reported by ClinicalTrials.gov.
    • 02 Aug 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top